Inovio Pharmaceuticals
INO
#8716
Rank
โ‚ฌ0.10 B
Marketcap
3,88ย โ‚ฌ
Share price
0.25%
Change (1 day)
-15.60%
Change (1 year)

Revenue for Inovio Pharmaceuticals (INO)

Revenue in 2024 (TTM): โ‚ฌ0.55 Million

According to Inovio Pharmaceuticals's latest financial reports the company's current revenue (TTM ) is โ‚ฌ0.56 Million. In 2023 the company made a revenue of โ‚ฌ0.75 Million a decrease over the revenue in the year 2022 that were of โ‚ฌ9.56 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Inovio Pharmaceuticals from 1999 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) โ‚ฌ0.55 M-26.42%
2023 โ‚ฌ0.75 M-92.13%
2022 โ‚ฌ9.56 M510.49%
2021 โ‚ฌ1.56 M-73.99%
2020 โ‚ฌ6.02 M64.15%
2019 โ‚ฌ3.67 M-86.22%
2018 โ‚ฌ26.64 M-24.28%
2017 โ‚ฌ35.18 M4.65%
2016 โ‚ฌ33.62 M-9.38%
2015 โ‚ฌ37.1 M331.58%
2014 โ‚ฌ8.59 M-11.83%
2013 โ‚ฌ9.75 M213.2%
2012 โ‚ฌ3.11 M-58.72%
2011 โ‚ฌ7.54 M63.27%
2010 โ‚ฌ4.61 M-27.43%
2009 โ‚ฌ6.36 M324.25%
2008 โ‚ฌ1.5 M-54.43%
2007 โ‚ฌ3.29 M25.27%
2006 โ‚ฌ2.62 M-43.05%
2005 โ‚ฌ4.61 M436.43%
2004 โ‚ฌ0.86 M1245.12%
2003 โ‚ฌ0.06 M-64.72%
2002 โ‚ฌ0.18 M
2000 โ‚ฌ5.9 M-32.44%
1999 โ‚ฌ8.74 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
โ‚ฌ53.11 B 9,401,125.63%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ83.70 B 14,816,942.57%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ18.75 M 3,219.71%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ47.66 B 8,437,720.49%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
โ‚ฌ59.63 B 10,556,299.41%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ38.42 B 6,800,963.51%๐Ÿ‡ฌ๐Ÿ‡ง UK
โ‚ฌ26.53 B 4,697,471.55%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0.6 M 6.76%๐Ÿ‡บ๐Ÿ‡ธ USA